- Home
- CYBN vs PLBY Comparison
CYBN vs PLBY Comparison
Compare CYBN & PLBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- PLBY
- Stock Information
- Founded
- CYBN 2019
- PLBY 1953
- Country
- CYBN Canada
- PLBY United States
- Employees
- CYBN N/A
- PLBY N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- PLBY Recreational Games/Products/Toys
- Sector
- CYBN Health Care
- PLBY Consumer Discretionary
- Exchange
- CYBN Nasdaq
- PLBY Nasdaq
- Market Cap
- CYBN 147.4M
- PLBY 139.8M
- IPO Year
- CYBN N/A
- PLBY N/A
- Fundamental
- Price
- CYBN $5.66
- PLBY $1.82
- Analyst Decision
- CYBN Strong Buy
- PLBY Strong Buy
- Analyst Count
- CYBN 4
- PLBY 1
- Target Price
- CYBN $71.25
- PLBY $3.00
- AVG Volume (30 Days)
- CYBN 1.2M
- PLBY 468.8K
- Earning Date
- CYBN 11-13-2025
- PLBY 11-12-2025
- Dividend Yield
- CYBN N/A
- PLBY N/A
- EPS Growth
- CYBN N/A
- PLBY N/A
- EPS
- CYBN N/A
- PLBY N/A
- Revenue
- CYBN N/A
- PLBY $119,510,000.00
- Revenue This Year
- CYBN N/A
- PLBY $5.20
- Revenue Next Year
- CYBN N/A
- PLBY $8.32
- P/E Ratio
- CYBN N/A
- PLBY N/A
- Revenue Growth
- CYBN N/A
- PLBY N/A
- 52 Week Low
- CYBN $4.81
- PLBY $0.90
- 52 Week High
- CYBN $11.39
- PLBY $2.44
- Technical
- Relative Strength Index (RSI)
- CYBN 41.21
- PLBY 69.89
- Support Level
- CYBN $5.52
- PLBY $1.57
- Resistance Level
- CYBN $6.30
- PLBY $1.73
- Average True Range (ATR)
- CYBN 0.32
- PLBY 0.11
- MACD
- CYBN -0.07
- PLBY 0.04
- Stochastic Oscillator
- CYBN 19.61
- PLBY 93.22
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
About PLBY PLBY Group Inc.
Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.